文献速递区域麻醉与超声疼痛医学

iPACK阻滞联合局部浸润镇痛与连续收肌管阻滞在全膝关节置换术后的镇痛效果

Analgesic efficacy of infiltration between the popliteal artery and capsule of the knee (iPACK) block added to local infiltration analgesia and continuous adductor canal block after total knee arthroplasty: a randomized clinical trial.
PubMed 文献 · Reg Anesth Pain Med · 2020-08-23

这项双盲随机对照试验纳入72例全膝关节置换术患者,比较局部浸润镇痛联合连续收肌管阻滞(LIA+CACB)基础上加用iPACK阻滞是否减少术后阿片类药物需求。结果显示24小时累积静脉吗啡消耗量组间无显著差异(1.31±1.85 mg vs 0.61±1.25 mg,p=0.08),但iPACK组术后第1、2天Timed Up and Go测试评分更低且住院时间更短。

要点

  • 加用iPACK阻滞未显著减少TKA术后24小时静脉吗啡消耗量。
  • iPACK组术后第1、2天Timed Up and Go测试评分更低,住院时间更短。
  • 两组总体疼痛评分无临床显著差异。

核心结论

  • 在LIA联合CACB基础上加用iPACK阻滞不减少术后阿片类药物消耗,也不改善镇痛效果。
  • 但加用iPACK阻滞可能改善术后即刻功能表现并缩短住院时间。

研究设计与样本

  • 双盲随机对照试验,共纳入72例全膝关节置换术患者。
  • 患者随机分为LIA+CACB组或iPACK+LIA+CACB组。

主要发现

  • 术后24小时累积静脉吗啡消耗量组间无显著差异(LIA+CACB组1.31±1.85 mg vs iPACK+LIA+CACB组0.61±1.25 mg,p=0.08)。
  • 两组总体疼痛评分无临床显著差异。
  • iPACK+LIA+CACB组术后第1天和第2天Timed Up and Go测试评分更低(p<0.05)。
  • iPACK+LIA+CACB组住院时间更短(p<0.05)。

临床怎么用

  • 对于TKA术后采用LIA联合CACB镇痛的患者,加用iPACK阻滞不应以减少阿片类药物消耗为主要目的。
  • 若关注术后早期功能恢复和缩短住院时间,可考虑加用iPACK阻滞。

局限性

  • 原文摘要未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A combination of motor-sparing analgesia with local infiltration analgesia (LIA) and continuous adductor canal block (CACB) may improve postoperative pain and functional recovery for total knee arthroplasty (TKA). We hypothesized that the addition of a novel technique for posterior knee block, known as the infiltration between the popliteal artery and capsule of the knee (iPACK) block, to LIA with CACB would reduce opioid requirements. METHODS: In this double-blinded randomized controlled trial, 72 patients were assigned to receive either LIA with CACB (LIA+CACB group) or iPACK block with LIA and CACB (iPACK+LIA+CACB group). The primary outcome was cumulative postoperative intravenous morphine consumption within 24 hours. The secondary outcomes included numerical rating scale pain scores, incidence of posterior knee pain, performance test results, patient satisfaction, length of stay, and adverse events. RESULTS: Morphine consumption within 24 hours postoperatively showed no significant intergroup difference (LIA+CACB; 1.31±1.85 mg vs iPACK+LIA+CACB; 0.61±1.25 mg, p=0.08). There were no clinically significant differences in the overall pain scores between the groups. The lower Timed Up and Go test scores on postoperative days 1 and 2, along with a shorter duration of hospitalization, were found in the iPACK+LIA+CACB group (p<0.05). CONCLUSION: The addition of an iPACK block to the LIA and CACB does not reduce the postoperative opioid consumption nor improve analgesia. However, it may improve immediate functional performance and reduce the length of hospitalization after TKA. TRIAL REGISTRATION NUMBER: TCTR20180702001.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Vichainarong C, Kampitak W, Tanavalee A, et al. Analgesic efficacy of infiltration between the popliteal artery and capsule of the knee (iPACK) block added to local infiltration analgesia and continuous adductor canal block after total knee arthroplasty: a randomized clinical trial. Reg Anesth Pain Med. 2020. PMID: 32839253. doi:10.1136/rapm-2020-101396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。